Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease

dc.contributor.authorUranga, Jose Antonio
dc.contributor.authorLópez Miranda, Visitación
dc.contributor.authorFelipe, Lombo
dc.contributor.authorAbalo, Raquel
dc.date.accessioned2024-04-02T09:27:13Z
dc.date.available2024-04-02T09:27:13Z
dc.date.issued2016-06-03
dc.description.abstractInflammatory bowel diseases (ulcerative colitis; Crohn’s disease) are debilitating relapsing inflammatory disorders affecting the gastrointestinal tract, with deleterious effect on quality of life, and increasing incidence and prevalence. Mucosal inflammation, due to altered microbiota, increased intestinal permeability and immune system dysfunction underlies the symptoms and may be caused in susceptible individuals by different factors (or a combination of them), including dietary habits and components. In this review we describe the influence of the Western diet, obesity, and different nutraceuticals/functional foods (bioactive peptides, phytochemicals, omega 3-polyunsaturated fatty acids, vitamin D, probiotics and prebiotics) on the course of IBD, and provide some hints that could be useful for nutritional guidance. Hopefully, research will soon offer enough reliable data to slow down the spread of the disease and to make diet a cornerstone in IBD therapy.es
dc.identifier.citationUranga, J.A., López-Miranda, V., Lombó, F. et al. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease. Pharmacol. Rep 68, 816–826 (2016). https://doi.org/10.1016/j.pharep.2016.05.002es
dc.identifier.doi10.1016/j.pharep.2016.05.002es
dc.identifier.issn1734-1140
dc.identifier.issn2299-5684
dc.identifier.urihttps://hdl.handle.net/10115/31855
dc.language.isoenges
dc.publisherSpringeres
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses
dc.subjectInflammatory bowel diseasees
dc.subjectulcerative colitises
dc.subjectCrohn’s diseasees
dc.subjectnutraceuticalses
dc.subjectfunctional foodses
dc.titleFood, nutrients and nutraceuticals affecting the course of inflammatory bowel diseasees
dc.typeinfo:eu-repo/semantics/reviewes

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Pharmacol Reps 2016.pdf
Tamaño:
1.86 MB
Formato:
Adobe Portable Document Format
Descripción:
Documento final enviado

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
2.67 KB
Formato:
Item-specific license agreed upon to submission
Descripción: